Scot Weinberger
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$9.5MFederal grants as PI11 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
11 awards · $9.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 1, 2023 | NIH | SBIR Phase I Liquid Chromatography Flash Oxidation (LC-Fox™) Protein Footprinting System | $350K | GENNEXT TECHNOLOGIES, INC. |
| Mar 9, 2022 | NIH | SBIR Phase II In-cell Automated Flash Oxidation (IC-AutoFox™) Protein Footprinting System | $2.5M | GENNEXT TECHNOLOGIES, INC. |
| May 1, 2021 | NIH | SBIR Phase I Multi-Wavelength Fluorescence Radical Dosimetry for Real-Time Assessment of Protein Footprinting Radical Yield | $251K | GENNEXT TECHNOLOGIES, INC. |
| Apr 1, 2021 | NIH | SBIR Phase II Software for Determining Proteoform Heterogeneity and Protein Expression Fidelity | $1.7M | GENNEXT TECHNOLOGIES, INC. |
| Apr 1, 2020 | NIH | SBIR Phase I In-Cell Radical Dosimetry (ICRD) for improved in vivo Fast Photo-oxidation of Proteins Hydroxyl Radical Protein Footprinting | $262K | GENNEXT TECHNOLOGIES, INC. |
| Feb 1, 2020 | NIH | SBIR Phase II FoxWare™, An Advanced Data Analysis Package for Hydroxyl Radical Foot-Printing Higher Order Structural Analysis | $1.4M | GENNEXT TECHNOLOGIES, INC. |
| Apr 1, 2019 | NIH | SBIR Phase II Tailoring the Hydroxyl Radical Foot-Printing Approach to Provide a Solution for the Higher Order Structural Analysis Needs of the Biopharmaceutical Industry | $2.1M | GENNEXT TECHNOLOGIES, INC. |
| 2019 | NIH | STTR Phase I Software for Determining Proteoform Heterogeneity and Protein Expression Fidelity | $225K | GENNEXT TECHNOLOGIES, INC. with UNIVERSITY OF GEORGIA |
| Apr 1, 2018 | NIH | SBIR Phase I Metal-oxide Photo-Oxidation of Proteins (MoPOP) for Biopharmaceutical Higher Order Structural Analysis | $225K | GENNEXT TECHNOLOGIES, INC. |
| 2018 | NIH | SBIR Phase I FoxWare, An Advanced Data Analysis Package for Hydroxyl Radical Foot-Printing Higher Order Structural Analysis | $224K | GENNEXT TECHNOLOGIES, INC. |
| Sep 1, 2017 | NIH | SBIR Phase I Tailoring the Hydroxyl Radical Footprinting Approach to Provide a Solution for the Higher Order Structural Analytical Needs of the Biopharmaceutical Industry | $225K | GENNEXT TECHNOLOGIES, INC. |
Peer ranks
Federal funding#83
Awards as PI#114
Patents#505
Companies
- GENNEXT TECHNOLOGIES, INC.Linked by awards · Medtech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.